Is Ketamine Living Up to the Promise for Depression?
After years of dormancy, psychiatric drug development is showing signs of life. There is the novel antipsychotic lumateperone, recently approved for adults with schizophrenia. Brexanolone was approved last year for postpartum depression. And perhaps generating the most attention lately among psychiatrists — and people with depression — is the use of ketamine and esketamine for […]
Is Ketamine Living Up to the Promise for Depression? Read More »